- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06659302
Feasibility of a Virtual Mental Health Intervention for Children with Congenital Heart Disease
Evaluating the Feasibility of a Virtual Stepped Mental Health Care Intervention for Children with Congenital Heart Disease
Children with congenital heart disease are at much higher risk for behavioral and emotional difficulties in early childhood and beyond 1. However, intervention programs aimed at this population are limited and few have explored the efficacy of behavioral parent training on child behavior and parent stress in children with CHD. Few evidence-based behavior intervention programs are available in the community for families of children with CHD and behavioral struggles and many families struggle to stick with long-term treatment given the multiple appointments and responsibilities that are often already associated in parenting children with chronic health conditions. As such, more targeted, shorter and more accessible interventions are very needed. Established internet-based treatments such as I-InTERACT-North, are particularly well-suited for adaptation to stepped-care delivery due to prior implementation success, readily adaptable intensity of online content and therapist contact.
This study will evaluate whether I-InTERACT North is a feasible intervention to implement in a step-care model and whether it is acceptable to families and impacts behavior and family functioning.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
I-InTERACT-North was designed to be delivered online with a longstanding record of success in virtual service among children and families with behavioural challenges and parenting stress associated with acquired brain injury. The program contains key components that can be used in a stepped-care model to address parent stress and child behavioural concerns: 1) psychoeducation regarding the impact of heart disease on brain development, as well as behavior and emotion regulation skills in children, and 2) parenting strategies that foster responsiveness and consistency in the home. These two components have been shown to be effective in optimizing child behavior outcomes and reducing parental distress.
The program combines online learning modules with 1:1 parent-coaching provided in the family's home by videoconferencing. Coaching sessions reinforce content and provide direct live coaching on parent-responsivity skills. There is flexibility in when online modules are completed and video conference sessions are scheduled, essential considerations for families balancing simultaneous work and child-care demands. One of the co-investigators (Williams) recently completed an open-label pre-post pilot feasibility trial of the transdiagnostic program at SickKids among families following neonatal medical illness/injury, an important cause of early behaviour and emotional regulation issues, with promising implementation outcomes and preliminary indices of improvement in child behaviour and parent stress.15 In this study, approximately 69% of eligible families contacted consented; and 86% enrolled completed the 7-session program. Parents and therapists reported high overall satisfaction with the program (100%), including acceptability of both the online modules (95%) and the videoconference sessions (95%). Child behaviour (d=0.50, See Figure 1) and parenting confidence and skill (d = 0.45, 0.64) also improved. Among participants who did not complete the program, families cited lack of time as the number one barrier to participation. This stepped care approach directly addresses this concern by matching mental health services to the needs of families.
The current study leverages an existing evidenced-based virtual program (I-InTERACT-North) that contains key components to address stress and child behaviour concerns within a stepped-care model: 1) general psychoeducation regarding the impact of medical diagnosis on children and families, and 2) graduated intensity in coaching of parenting strategies that foster responsiveness, warmth and consistency in the home. These two components have longstanding effectiveness in optimizing child behavior and reducing parental distress.
Study Purpose and Objectives 2.1 Primary Objectives
- To evaluate whether a stepped-care adaptation of I-InTERACT-North can be implemented as planned, measuring fidelity, acceptability, and engagement.
- To assess accrual and dropout rates at each step.
- To investigate program fidelity between our site and the main intervention site
- To examine participant and care provider perceptions regarding intervention acceptability and satisfaction.
- To evaluate the relationship between parent and child needs, key social demographic factors and program participation
Secondary Objectives
1) To measure the association between pre-and post-intervention short-term child behaviour and parent stress outcomes, parent responsivity and behavioural management skills, with hypothesized greater improvement following higher steps of engagement.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marsha Vasserman, Psy.D.
- Phone Number: 403-955-5048
- Email: marsha.vasserman@ahs.ca
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Consent provided
- parent of a child aged 3 to 9 years,
- parent reported concerns regarding their child's externalizing behaviour
- child is followed in cardiology clinic at Alberta Children's Hospital.
- parent is able to speak and read English.
Exclusion Criteria:
- Child is outside of age range of the program (<3 or > 9 years of age)
- Significant major medical issues requiring ongoing inpatient care
- Currently participating in an equivalent family/parent therapy program (e.g., Incredible Years Parenting Program (IYPP), Positive Parenting Program (Triple P))
- Inability to read/write and communicate in English
- Inability to consent or complete study measures electronically (online)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intro meeting
Participants will be sent baseline questionnaires online through REDCap (Research Electronic Data Capture; see Appendix 1-email templates), a secure web application, and housed on a secure server.
Participants will access a unique REDCap survey link via email to complete questionnaire measures after consenting to the study.
After completion of the baseline questionnaires, participants will be connected with an I-InTERACT-North therapist for an Introductory Meeting to conduct a baseline elevation session.
If participants do not wish to enroll in the full program, post-intervention questionnaires will be administered online through REDCap post step 1.
If they wish to proceed to the full program, they will complete the questionnaires after step 2 or 3.
|
Initial questionnaires completed followed by initial meeting with therapist for baseline evaluation.
|
|
Experimental: Two sessions
Step 2: Parents who were identified as high stress/behaviour on the baseline questionnaires and/or based on the introduction meeting in Step 1, will be invited to participate in the initial two therapist-guided I-InTERACT-North sessions that focus on family stress and positive parenting strategies.
Each session includes both an online psychoeducational module and a video conferencing session with a therapist.
Session frequency is subject to change based on parent schedule preference and availability.
Each session will last 60 minutes and will be video recorded (with consent from the participants).
Sessions will be delivered to parents using Zoom, a secure online video conferencing platform (https://zoom.us/).
If they wish to proceed to the full program, they will complete the questionnaires after step 3.
|
Two online modules completed by family plus two online zoom coaching sessions with therapist.
|
|
Experimental: Full Program
Step 3: Families will be invited to participate in the full I-InTERACT-North program.
The full program will provide an additional 5 online modules with live therapist videoconference coaching sessions.
All sessions are strongly encouraged but for parents who do not complete the additional sessions, we will track what is completed and parents may still complete outcome measures.
Based on previous work, average time of completion for the full program is 8-12 weeks.
Each session will last 60 minutes and will be video recorded (with consent from the participants).
Sessions will be delivered to parents using Zoom, a secure online video conferencing platform (https://zoom.us/).
Before each session, parents will receive a meeting invitation link via email.
After completing the program, participants will complete online questionnaires through REDCap.
All participants will be invited to complete study follow-up questionnaires.
|
Full program will consist of an additional 5 sessions with online modules and virtual coaching sessions with therapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accrual Rate
Time Frame: 56 weeks from first participant contact
|
the proportion of invited participants who consent to participate
|
56 weeks from first participant contact
|
|
Dropout Rate
Time Frame: 70 weeks after contacting first participant
|
the proportion of participants who drop out of the study during Step 1, 2 or 3
|
70 weeks after contacting first participant
|
|
Fidelity:
Time Frame: 70 weeks after contacting first participant
|
the proportion of content covered from therapy protocols and questionnaires completed;
|
70 weeks after contacting first participant
|
|
Acceptability & Satisfaction
Time Frame: 70 weeks after first participant contact
|
the proportion of participants and therapists who rate the program as satisfactory or very satisfactory based on post-intervention; dropouts considered not-satisfied
|
70 weeks after first participant contact
|
|
Engagement & Adherence:
Time Frame: 70 weeks after first participant contact
|
the amount of time (in hours/weeks) to complete intervention steps will be estimated by parents and therapists (for steps 2 and 3), the number of sessions completed an adherence index (sessions completed/total sessions scheduled)
|
70 weeks after first participant contact
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child behavior concerns and intensity baseline
Time Frame: 1 day after signing consent
|
Child behavior concerns and intensity will be measured using the Eyberg Child Behavior Inventory (ECBI), a 36-item checklist of mental health concerns.
Following Step 1, reported elevated scores (T score>60) will be considered at-risk.
|
1 day after signing consent
|
|
Parental stress baseline
Time Frame: 1 day after signing consent
|
The Depression Anxiety and Stress Scale Short Form (DASS-21) will measure general distress in parents, with three subscales (depression, anxiety, and stress) with strong internal consistency, adequate construct validity and sensitivity to parent therapy; using cut-off scores of 60 for step 2
|
1 day after signing consent
|
|
Child behavior at end of study
Time Frame: up to 25 weeks after signing consent
|
ECBI will be used to measure child behavior concerns
|
up to 25 weeks after signing consent
|
|
Parent stress end of study
Time Frame: up to 25 weeks after signing consent
|
DASS-21 will be used to measure parent stress
|
up to 25 weeks after signing consent
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Burek B, Ford MK, Hooper M, Green R, Kohut SA, Andrade BF, Ravi M, Sananes R, Desrocher M, Miller SP, Wade SL, Williams TS. Transdiagnostic feasibility trial of internet-based parenting intervention to reduce child behavioural difficulties associated with congenital and neonatal neurodevelopmental risk: introducing I-InTERACT-North. Clin Neuropsychol. 2021 Jul;35(5):1030-1052. doi: 10.1080/13854046.2020.1829071. Epub 2020 Oct 8.
- Wiggins TL, Sofronoff K, Sanders MR. Pathways Triple P-positive parenting program: effects on parent-child relationships and child behavior problems. Fam Process. 2009 Dec;48(4):517-30. doi: 10.1111/j.1545-5300.2009.01299.x.
- Masten AS, Hubbard JJ, Gest SD, Tellegen A, Garmezy N, Ramirez M. Competence in the context of adversity: pathways to resilience and maladaptation from childhood to late adolescence. Dev Psychopathol. 1999 Winter;11(1):143-69. doi: 10.1017/s0954579499001996.
- Antonini TN, Raj SP, Oberjohn KS, Cassedy A, Makoroff KL, Fouladi M, Wade SL. A pilot randomized trial of an online parenting skills program for pediatric traumatic brain injury: improvements in parenting and child behavior. Behav Ther. 2014 Jul;45(4):455-68. doi: 10.1016/j.beth.2014.02.003. Epub 2014 Feb 13.
- Cohen GH, Tamrakar S, Lowe S, Sampson L, Ettman C, Linas B, Ruggiero K, Galea S. Comparison of Simulated Treatment and Cost-effectiveness of a Stepped Care Case-Finding Intervention vs Usual Care for Posttraumatic Stress Disorder After a Natural Disaster. JAMA Psychiatry. 2017 Dec 1;74(12):1251-1258. doi: 10.1001/jamapsychiatry.2017.3037.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB24-1232
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease (CHD)
-
Ottawa Heart Institute Research CorporationUniversity of Ottawa Heart Institute, CanadaRecruitingCongenital Heart Disease (CHD)Canada
-
Assiut UniversityNot yet recruitingCongenital Heart Disease (CHD)Egypt
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Carelon ResearchNot yet recruitingCongenital Heart Disease (CHD)United States
-
Carelon ResearchNot yet recruitingCongenital Heart Disease (CHD)United States
-
University Hospital, BordeauxNot yet recruiting
-
University Hospital, BordeauxRecruiting
-
The Hospital for Sick ChildrenCompletedCongenital Heart Disease (CHD)Canada
-
University College, LondonSociety for Cardiothoracic Surgery in Great Britain & Ireland; British Congenital...Unknown
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
Clinical Trials on I-inTERACT North Step 1
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Recruiting
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital Colorado; Nationwide Children's Hospital; MetroHealth Medical... and other collaboratorsCompletedTraumatic Brain InjuryUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingParent-Child Relations | Parenting | Child Behavior Problem | PretermUnited States
-
Children's Hospital Medical Center, CincinnatiU.S. Department of EducationCompletedTraumatic Brain InjuryUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHaematological Malignancies | SarcomasItaly
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Taisho Pharmaceutical Co., Ltd.CompletedHealthy VolunteerJapan
-
University Hospital, MontpellierDirection Générale de l'Offre de SoinsRecruitingNeurodevelopmental Disorders | Autism Spectrum Disorder | SiblingsFrance
-
Green Cross CorporationKorean Center for Disease Control and PreventionCompletedInfluenzaKorea, Republic of
-
Groupe Hospitalier de la Region de Mulhouse et...CompletedHealthcare ProfessionnalsFrance